UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants

Journal of neuroscience research, 2012-12, Vol.90 (12), p.2306-2316

2012

Volltextzugriff (PDF)

Biochemical and pathological characterization of Lrrk2

Annals of neurology, 2006-02, Vol.59 (2), p.315-322

2006

Volltextzugriff (PDF)

E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment

The Journal of biological chemistry, 2011-10, Vol.286 (40), p.35104-35118

2011

Volltextzugriff (PDF)

Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2

Biochemical and biophysical research communications, 2009-01, Vol.378 (3), p.473-477

2009

Volltextzugriff (PDF)

LRRK2 phosphorylates novel tau epitopes and promotes tauopathy

Acta neuropathologica, 2013-12, Vol.126 (6), p.809-827

2013

Volltextzugriff (PDF)

α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of parkinson disease

Neurotoxicology (Park Forest South), 2011-10, Vol.32 (5), p.622-629

2011

Volltextzugriff (PDF)

G2019S pathogenic mutation disrupts sensitivity of leucine-rich repeat kinase 2 to manganese kinase inhibition

Journal of neurochemistry, 2010-10, Vol.115 (1), p.36-46

2010

Volltextzugriff (PDF)

Studies of protein aggregation in A53T α-synuclein transgenic, Tg2576 transgenic, and P246L presenilin-1 knock-in cross bred mice

Neuroscience letters, 2012-01, Vol.507 (2), p.137-142

2012

Volltextzugriff (PDF)

Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations

Movement disorders, 2009-01, Vol.24 (1), p.32-39

2009

Volltextzugriff (PDF)

Leucine-Rich Repeat Kinase 2 Expression Leads to Aggresome Formation That Is Not Associated With α-Synuclein Inclusions

Journal of neuropathology and experimental neurology, 2009-07, Vol.68 (7), p.785-796

2009

Volltextzugriff (PDF)

Lack of evidence for Lrrk2 in α-synuclein pathological inclusions

Annals of neurology, 2006-11, Vol.60 (5), p.618-619

2006

Volltextzugriff (PDF)

Corrigendum to “Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2” [Biochem. Biophys. Res. Commun. 378 (2009) 473–477]

Biochemical and biophysical research communications, 2009-09, Vol.387 (2), p.419-420

2009

Volltextzugriff (PDF)

α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of parkinson disease: Unifying Mechanisms of Neurological Disorders: Scientific, Translational, and Clinical Implications

Neurotoxicology (Park Forest South), 2011, Vol.32 (5), p.622-629

2011

Volltextzugriff (PDF)

Leucine-Rich Repeat Kinase 2 Expression Leads to Aggresome Formation That Is Not Associated With [alpha]-Synuclein Inclusions

Journal of neuropathology and experimental neurology, 2009-07, Vol.68 (7), p.785

2009

Volltextzugriff (PDF)

The pathological and biochemical characterization of leucine-rich repeat kinase 2 in Parkinson's disease

Covy, Jason P

2010

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(14)
Dissertationen
(1)

Sprache

Englisch
(15)
Japanisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants

Biochemical and pathological characterization of Lrrk2

E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment

Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2

LRRK2 phosphorylates novel tau epitopes and promotes tauopathy

α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of parkinson disease

G2019S pathogenic mutation disrupts sensitivity of leucine-rich repeat kinase 2 to manganese kinase inhibition

Studies of protein aggregation in A53T α-synuclein transgenic, Tg2576 transgenic, and P246L presenilin-1 knock-in cross bred mice

Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations

Leucine-Rich Repeat Kinase 2 Expression Leads to Aggresome Formation That Is Not Associated With α-Synuclein Inclusions

Lack of evidence for Lrrk2 in α-synuclein pathological inclusions

Corrigendum to “Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2” [Biochem. Biophys. Res. Commun. 378 (2009) 473–477]

α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of parkinson disease: Unifying Mechanisms of Neurological Disorders: Scientific, Translational, and Clinical Implications

Leucine-Rich Repeat Kinase 2 Expression Leads to Aggresome Formation That Is Not Associated With [alpha]-Synuclein Inclusions

The pathological and biochemical characterization of leucine-rich repeat kinase 2 in Parkinson's disease

Suchergebnisse filtern